MODERN OSTEOARTHRITIS THERAPY: ALFLUTOP IN CLINICAL PRACTICE, EXPERIMENTAL AND CLINICAL DATA
The article discusses experimental data that demonstrated the ability of Aflutop to stimulate proliferation and regeneration of chondrocytes, to inhibate in vitro extracellular release of IL-6 cytokine and IL-8 chemokine compared to control cells, to inhibit VEGF, a proangiogenic factor, a biochemic...
Main Author: | N. V. Chichasova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2159 |
Similar Items
-
Alflutop in osteoarthritis therapy
by: G. V. Lukina, et al.
Published: (2004-06-01) -
Alflutop clinical efficacy assessment in osteoarthritis (two-years study)
by: V. N. Chodyrev, et al.
Published: (2003-02-01) -
CHONDROPROTECTIVE DRUG ALFLUTOP IN THE TREATMENT OF OSTEOARTHRITIS
by: G V Lukina, et al.
Published: (2001-04-01) -
EVALUATION OF THE ROLE OF ALFLUTOP IN THE OSTEOARTHRITIS TREATMENT: INDICATIONS, CLINICAL EFFICACY, TOLERABILITY AND IMPACT ON QUALITY OF LIFE
by: L. K. PESHEKHONOVA, et al.
Published: (2016-12-01) -
RADIOLOGICAL PROGRESSION OF KNEE OSTEOARTHRITIS ON THE BACKGROUND OF PROLONGED TREATMENT WITH ALFLUTOP (5 YEAR FOLLOW-UP)
by: M. S. Svetlova
Published: (2017-12-01)